CIK 0001735438 · Non-accelerated filer<br>Smaller reporting company
MeiraGTx Holdings plc
Sign in to watch- Ticker
- MGTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981448305
- Phone
- 646-860-7985
- Business address
- 655 THIRD AVENUE, SUITE 1115, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,710,812
- in 3 filings, $1.7M under 10b5-1 plans
Net −$1,710,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 30 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-14 | Zeldin Robert K CHIEF MEDICAL OFFICER | Option exercise | +37,500 | 142,572 | ||
| 2025-01-14 | Zeldin Robert K CHIEF MEDICAL OFFICER | Shares withheld for taxes | −15,149 | $5.77 | $87K | 127,423 |
| 2025-01-14 | Zeldin Robert K CHIEF MEDICAL OFFICER | Option exercise · Restricted Share Units | −37,500 | 0 | ||
| 2025-01-14 | Wollin Robert J GENERAL COUNSEL AND SECRETARY | Option exercise | +5,000 | 23,671 | ||
| 2025-01-14 | Wollin Robert J GENERAL COUNSEL AND SECRETARY | Shares withheld for taxes | −2,909 | $5.77 | $17K | 20,762 |
| 2025-01-14 | Wollin Robert J GENERAL COUNSEL AND SECRETARY | Option exercise · Restricted Share Units | −5,000 | 0 | ||
| 2025-01-14 | Naylor Stuart CHIEF DEV. OFFICER | Option exercise | +23,750 | 607,954 | ||
| 2025-01-14 | Naylor Stuart CHIEF DEV. OFFICER | Shares withheld for taxes | −11,163 | $5.77 | $64K | 596,791 |
| 2025-01-14 | Naylor Stuart CHIEF DEV. OFFICER | Option exercise · Restricted Share Units | −23,750 | 0 | ||
| 2025-01-14 | Giroux Richard CFO & COO | Option exercise | +25,000 | 887,166 | ||
| 2025-01-14 | Giroux Richard CFO & COO | Shares withheld for taxes | −13,219 | $5.77 | $76K | 873,947 |
| 2025-01-14 | Giroux Richard CFO & COO | Option exercise · Restricted Share Units | −25,000 | 0 | ||
| 2025-01-14 | Forbes Alexandria PRESIDENT & CEO | Option exercise | +30,000 | 1,413,441 | ||
| 2025-01-14 | Forbes Alexandria PRESIDENT & CEO | Shares withheld for taxes | −15,863 | $5.77 | $92K | 1,397,578 |
| 2025-01-14 | Forbes Alexandria PRESIDENT & CEO | Option exercise · Restricted Share Units | −30,000 | 0 | ||
| 2025-01-08 | Forbes Alexandria PRESIDENT & CEO | Sale 10b5-1 | −11,661 | $6.30 | $73K | 1,383,441 |
| 2025-01-07 | Zeldin Robert K CHIEF MEDICAL OFFICER | Option exercise | +17,500 | 111,958 | ||
| 2025-01-07 | Zeldin Robert K CHIEF MEDICAL OFFICER | Shares withheld for taxes | −6,886 | $6.34 | $44K | 105,072 |
| 2025-01-07 | Zeldin Robert K CHIEF MEDICAL OFFICER | Option exercise · Restricted Share Units | −17,500 | 17,500 | ||
| 2025-01-07 | Forbes Alexandria PRESIDENT & CEO | Option exercise 10b5-1 | +62,500 | 1,463,989 |
Page 7 of 21 · 411 trades